Status:
NOT_YET_RECRUITING
A Predictive Model Based on Quantitative Fecal Immunochemical Test Can Stratify the Risk of CRC in an Organized Screening Program
Lead Sponsor:
Catholic University of the Sacred Heart
Collaborating Sponsors:
European Society of Gastrointestinal Endoscopy
Conditions:
Colorectal Cancer Screening
Eligibility:
All Genders
18+ years
Brief Summary
The COVID-19 pandemic has disrupted every aspect of medical care, including screening programs and preventive medical care . Organized FIT-based colorectal cancer screening programs make no exception,...
Eligibility Criteria
Inclusion
- All FIT+ patients awaiting to be scheduled for colonoscopy workup. Patients will be invited to undergo a colonoscopy, and depending on its outcome, patients are referred for surgery, postcolonoscopy surveillance, or further rounds of FIT.
Exclusion
- Individuals with a prevalent diagnosis of CRC are excluded from the program, as well as patients that have already undergone a high quality colonoscopy.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06607614
Start Date
November 1 2024
End Date
August 1 2026
Last Update
September 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.